BioMEMS Market Growth and Trends By Key Players: Cepheid, Bluechiip, Boston Scientific, Becton, Dickinson, Heimann Sensor, CapitalBio, Nanopass Technologies, Teledyne DALSA, Mec, OMRON and Micron Technology

Market Overview: -

BioMEMS market trends were valued at around USD 2.5 billion in 2014 and are anticipated to grow at CAGR of over 25% from 2016 to 2023. The industry is anticipated to attain over USD 8 billion over the forecast period owing to increasing adoption of medical instruments on the rental basis by the patient. In addition, rising mobile care applications is also expected to positively contribute significantly to the demand growth over the forecast period. Escalating application in mobile healthcare devices is the major trend for this industry.

BioMEMS market size is segmented on the basis of product, application and end user. Based on product, the industry can be segregated into implantable, injectable and others. Implantable BioMEMS market share can be sub-segmented into accelerometers, biochips, drug delivery devices, stents, gyroscopes, and biosensors. In addition, injectables can be further segregated into microneedles and micromodules. Other category includes inhalers, catheters, and micro motors.

Request for an in-depth table of contents for this report @ https://www.gminsights.com/request-toc/upcoming/344

Top Key Players: -

The chief players for the global BioMEMS market share include Cepheid, Bluechiip, Given Imaging and Integrated Sensing Systems. Boston Scientific, Becton, Dickinson, and Co (BD), Heimann Sensor, CapitalBio, Lepu Medical Technology, Nanopass Technologies, United Gene High-Tech Group, Teledyne DALSA, Mec, OMRON and Micron Technology are other notable participants.
Market share calculation in this report is not done based on companies covered in it. The calculation of BioMEMS market share is done based on a regional approach and countries covered. On request, additional companies can be covered as well as regional data for particular country/countries can be provided.
Regional Segmentation: -

Moreover, the industry is segmented by the application which includes diagnostic, therapeutic and tissue engineering. By end user, the industry can be bifurcated into pharmaceuticals, hospitals, food and agricultural industry, research centers and home diagnostics. Furthermore, the industry can be segregated by region which includes Asia Pacific, Latin America, North America, Europe, and MEA.

These devices have progressively become more perceptible especially in the healthcare sector by serving as solutions personalized to the requirements of several applications. The system assimilates actuators, miniature sensors, micro-optics, structural elements and microfluidics with controls and computation for the application required in the healthcare sector. Microsystems are employed in the healthcare sector for various applications. It improves the drug delivery system with the utilization of nanotechnology and also advances the treatment of cardiac diseases. These aspects are fueling demand growth for the global BioMEMS market size over the next few years.

Request for customization of this report @ https://www.gminsights.com/roc/344

Development of patient monitoring equipment system coupled with technological advancements in the devices is the chief factors responsible for the growth of the industry over the coming few years. In addition, high efficacy, low cost along with mounting aging population are also surging the demand growth over the forecast period. However, lack of adoption owing to high research and development cost coupled with long product development cycles are expected to hinder the industry growth from 2016 to 2023. Stringent regulatory guidelines are also acting as a challenge to the global BioMEMS market demand. Partnerships between pharmaceutical and engineering industries may act as the potential growth opportunity for the industry over the forecast period. In addition, emergences of personalized medicines are also identified as the key opportunity for this industry.

Microsystem devises market is deployed in four key healthcare sectors which include pharmaceutical, medical devices, medical home care, and in-vitro diagnostics. The stimulus for the acceptance of this technology is highly dependent on each individual sector. The implementation of microsystems is linked to the automation and sensibility constraints in the pharmaceutical sector. In addition, the in-vitro diagnostic sector involves cost reduction and portability features. Moreover, the medical devices industry is focused on further advancement in order to improve the functionalities. Furthermore, rising safety and security concerns among the consumers are expected to surge the demand for home care sector over the forecast period.

Browse Full Report @ https://bit.ly/2OBBKSQ

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com

This release was published on openPR.